Cargando…

Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit

BACKGROUND: Multidrug-resistant Acinetobacter (MDR-Ab) is one of the most important pathogens causing superinfections in COVID-19 patients hospitalised in the intensive care unit (ICU). The occurrence of MDR-Ab superinfection significantly impairs the prognosis of patients in the ICU. Overuse of ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mihalov, P., Hodosy, J., Koščálová, A., Čaprnda, M., Kachlíková, M., Jurenka, J., Bendžala, M., Sabaka, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513818/ https://www.ncbi.nlm.nih.gov/pubmed/37745269 http://dx.doi.org/10.1155/2023/4951273

Ejemplares similares

Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection – pilot prospective observational cohort study
por: Kachlíková, M., et al.
Publicado: (2020)

Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak
por: Sabaka, P., et al.
Publicado: (2021)

Lemierre syndrome caused by Klebsiella pneumoniae complicated by epidural abscess – Case report
por: Sabaka, Peter, et al.
Publicado: (2019)

Mycotic aneurysm as a hidden cause of treatment failure of pyelonephritis caused by Salmonella enterica, serovar Enteritidis
por: Sabaka, Peter, et al.
Publicado: (2020)

Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study
por: Jurenka, Ján, et al.
Publicado: (2022)

The effects of body weight loss and gain on arterial hypertension control: an observational prospective study
por: Sabaka, Peter, et al.
Publicado: (2017)

Postprandial changes of lipoprotein profile: effect of abdominal obesity
por: Sabaka, Peter, et al.
Publicado: (2013)

Acinetobacter Septicemia in Neonates Admitted to Intensive Care Units
por: Shete, Vishal B, et al.
Publicado: (2009)

Multidrug-resistant Acinetobacter baumannii infection in the intensive care unit
por: Wiwanitkit, Viroj
Publicado: (2014)

Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control
por: Cheon, Shinhye, et al.
Publicado: (2016)

Clinical and Economic Evaluation of Multidrug-Resistant Acinetobacter baumannii Colonization in the Intensive Care Unit
por: Lee, Hojin, et al.
Publicado: (2016)

Multidrug-resistant Acinetobacter spp. from hospital intensive care units in Brazilian Amazon
por: da Silva, Marcos Eduardo Passos, et al.
Publicado: (2023)

Multidrug Resistant Acinetobacter
por: Manchanda, Vikas, et al.
Publicado: (2010)

Whole-Genome Sequencing Elucidates the Epidemiology of Multidrug-Resistant Acinetobacter baumannii in an Intensive Care Unit
por: Mao, Pu, et al.
Publicado: (2021)

Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit
por: Russo, Alessandro, et al.
Publicado: (2021)

Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Causing Nosocomial Meningitis in the Neurological Intensive Care Unit
por: Fursova, Nadezhda K., et al.
Publicado: (2023)

Ozone fumigation successfully controlled and eradicated multidrug-resistant Acinetobacter baumanii from an intensive care unit
por: Stümpfle, R, et al.
Publicado: (2010)

A bronchofiberoscopy-associated outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit in Beijing, China
por: Xia, Yukun, et al.
Publicado: (2012)

Minocycline: The second important antimicrobial in multidrug-resistant Acinetobacter baumanii infections
por: Nair, Abhijit S.
Publicado: (2018)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022)

A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features
por: Boral, Baris, et al.
Publicado: (2019)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Acinetobacter baumannii: trends in antimicrobial resistance after relocation of an intensive care unit in tunisia
por: Koubaji, S, et al.
Publicado: (2015)

Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii
por: Miyasaki, Yoko, et al.
Publicado: (2013)

Lofgren syndrome in close temporal association with mild COVID-19 – Case report
por: Mihalov, Peter, et al.
Publicado: (2021)

Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: is there an association?
por: Kamalbeik, Sepideh, et al.
Publicado: (2014)

Multidrug-resistant Acinetobacter baumannii susceptible only to colistin outbreak in a cardiac surgical intensive care unit
por: Papadopoulos, K, et al.
Publicado: (2007)

Characterization of multidrug-resistant Acinetobacter ssp. strains isolated from medical intensive care units in Cali - Colombia.
por: Gómez, Rómel Fabian, et al.
Publicado: (2017)

Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients
por: Zeighami, Habib, et al.
Publicado: (2019)

High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit
por: Bai, Xiang-Rong, et al.
Publicado: (2020)

Controlling an Outbreak of Multidrug-resistant Acinetobacter baumannii in a Pediatric Intensive Care Unit: a Retrospective Analysis
por: Byun, Joung-Hee, et al.
Publicado: (2021)

Antimicrobial Susceptibility Patterns of an Emerging Multidrug Resistant Nosocomial Pathogen: Acinetobacter baumannii
por: Tewari, Rachna, et al.
Publicado: (2018)

Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2021)

Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns
por: Ghajavand, Hasan, et al.
Publicado: (2015)

Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia
por: Lee, Hongyeul, et al.
Publicado: (2016)

P231: Risk factors for Acinetobacter baumannii colonization and infection among patients admitted to intensive care units
por: Giannella, M, et al.
Publicado: (2013)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Multidrug-resistant Acinetobacter meningitis in children
por: Shah, Ira, et al.
Publicado: (2016)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_999hundbp98oomrbt7va32tfgn